Skip to content

Clinical trials

Lung Diseases trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Country / region: France Clear all

105 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20041
20051
20064
20072
20081
20094
20101
20111
20123
20134
20145
20153
20166
201710
20182
201910
20208
20216
20225
202310
20247
20254
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed54
Recruiting20
Terminated15
Unknown status7
Active, not recruiting7
Not yet recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca10
Assistance Publique - Hôpitaux de Paris8
Eli Lilly and Company4
Aeris Therapeutics3
Novartis Pharmaceuticals3
Revolution Medicines, Inc.3
University Hospital, Brest3
University Hospital, Montpellier3
Bayer2
Blueprint Medicines Corporation2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases105
Respiratory Tract Diseases32
Carcinoma, Non-Small-Cell Lung17
Lung Neoplasms17
Pulmonary Disease, Chronic Obstructive17
Neoplasms14
Neoplasms by Site12
Respiratory Tract Neoplasms12
Thoracic Neoplasms12
Asthma11

Trials

Showing 51 to 75 of 105. Each trial links to its page on Pharma Observatory.

5 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.